Figures and Tables

From the following article:

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Pedro Jares, Dolors Colomer & Elias Campo

Nature Reviews Cancer 7, 750-762 (October 2007)

doi:10.1038/nrc2230

Figure 1 - Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Figure 1

Cell cycle and DNA damage response pathway dysregulation in MCL.

Figure 2 - Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Figure 2

Schematic diagram representing the interplay between programmed cell death mechanisms and altered pathways in MCL.

Figure 3 - Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Figure 3

Proposed model of molecular pathogenesis in the development and progression of MCL.

Table 1 - Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Table 1

Common genetic alterations in mantle cell lymphoma

Table 2 - Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Table 2

New drug therapies in mantle cell lymphoma